5//SEC Filing
LINNIK MATTHEW D 5
Accession 0001209191-05-007919
CIK 0000920465other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:34 PM ET
Size
18.0 KB
Accession
0001209191-05-007919
Insider Transaction Report
Form 5
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Other
Common Stock
2004-06-30$1.48/sh+539$797→ 4,354 total - Other
Common Stock
2004-09-30$1.48/sh+455$673→ 4,809 total - Gift
Stock Option (right to buy)
2004-11-09$4.13/sh−2,254$9,298→ 788,746 totalExercise: $0.00From: 2003-02-03Exp: 2008-02-03→ Common Stock (2,254 underlying) - Gift
Stock Option (right to buy)
2004-11-09$3.81/sh−1,577$6,012→ 787,169 totalExercise: $0.00From: 2003-04-08Exp: 2008-04-08→ Common Stock (1,577 underlying) - Other
Common Stock
2004-12-31$1.42/sh+555$788→ 5,364 total
Holdings
- 5,364
Common Stock
- 787,169
Stock Option (right to buy)
→ Common Stock (787,169 underlying)
Footnotes (2)
- [F1]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
- [F2]Reporting only direct holdings, no transaction data is necessary
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237521
Filing Metadata
- Form type
- 5
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:34 PM ET
- Size
- 18.0 KB